Short Interest in Functional Brands Inc. (NASDAQ:MEHA) Decreases By 62.4%

Functional Brands Inc. (NASDAQ:MEHA) saw a large decrease in short interest in June. As of June 15th, there was short interest totaling 2,045,995 shares, a decrease of 62.4% from the May 31st total of 5,442,133 shares. Approximately 5.0% of the company’s stock are sold short. Based on an average daily trading volume, of 33,392,166 shares, the days-to-cover ratio is currently 0.1 days.

Wall Street Analyst Weigh In

Separately, Weiss Ratings upgraded shares of Functional Brands from a “sell (e-)” rating to a “sell (e)” rating in a research note on Friday, May 1st. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat, the stock currently has a consensus rating of “Sell”.

Functional Brands Trading Up 3.9%

NASDAQ:MEHA opened at $0.01 on Friday. Functional Brands has a 1 year low of $0.01 and a 1 year high of $8.00. The stock has a market cap of $226,537.90 and a P/E ratio of -0.02. The company has a debt-to-equity ratio of 0.25, a quick ratio of 0.64 and a current ratio of 1.20. The stock has a 50-day simple moving average of $0.07 and a 200-day simple moving average of $0.16.

Functional Brands (NASDAQ:MEHA) last posted its earnings results on Friday, May 15th. The company reported ($0.36) earnings per share for the quarter. The company had revenue of $1.65 million during the quarter.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in Functional Brands stock. Jane Street Group LLC bought a new stake in Functional Brands Inc. (NASDAQ:MEHA) during the fourth quarter, according to its most recent disclosure with the SEC. The firm bought 194,968 shares of the company’s stock, valued at approximately $37,000. Jane Street Group LLC owned about 1.19% of Functional Brands at the end of the most recent reporting period.

Functional Brands Company Profile

Our company operates in the nutraceutical supplement industry. We are a manufacturer and distributor of supplements in categories such as pain, energy, prenatal, general health, bone and joint, gastro, immunity, cardiac, detox, mental clarity & focus, sleep, prenatal and urinary. Our end markets focus on end-consumers through different channels that include pharmacies, US wholesalers, international distributors and direct-to-consumers sales. Our products are sold over the counter, and consumers do not need a prescription to purchase our products.